Merck demonstrates excellence across the board through its resilient revenue mix, expanding profitability, and stellar ...

Merck has bullish valuation metrics and is trading above its 30-week EMA with bullish long-term momentum. Learn why MRK stock ...

But then came news of Merck 's ( MRK 1.32%) plans to acquire Cidara for $221.50 per share, or a 109% premium to its prior ...

Millions of people take some kind of dietary supplement along with prescription medications. Here are the supplements and ...

Pogačar can already lay a claim to be cycling’s greatest of all time. He is butting heads and palmarès with Eddy Merckx. What ...

The 9.7% increase in the cost of Medicare Part B premiums for 2026 is due to several factors, including projected growth in ...

Valo will use its trove of patient records and biobank samples to pinpoint potential targets for Merck’s pipeline expansion.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

EdgeOne Medical, a professional service organization specializing in development and testing services for combination ...

The 10 branded pharmaceuticals stocks we track reported a satisfactory Q3. As a group, revenues beat analysts’ consensus ...

With roots dating back to 1891 and a portfolio that includes the blockbuster cancer immunotherapy Keytruda, Merck (NYSE:MRK) ...

The third quarter saw several notable deals that "underscore the strength and diversity of Wales' business landscape", according to the latest Experian Market IQ report.